source
- FDA advisory panel backs Moderna's experimental flu vaccine in adults 50-64, supports accelerated review for 65+The FDA's advisory committee voted unanimously to recommend Moderna's mRNA-1010 flu vaccine for adults aged 50 to 64, and also found it beneficial for those 65 and older. The 9-0 vote allows Moder…
- CMS recalculates 2026 Medicare Advantage star ratings, increasing program volatility and affecting $16 billion in bonusesFederal officials have issued a new memo that recalculates the quality ratings for 2026 Medicare Advantage plans. The change follows another lawsuit from insurers that contest lower star ratings,…